Company Filing History:
1 out of 74 
1 out of 12 Years Active: 2019
Title: The Innovations of Milan Basta
Introduction
Milan Basta is an accomplished inventor based in Potomac, MD (US). He has made significant contributions to the field of medical science, particularly in the treatment of cerebral ischemia. His innovative approach combines immunoglobulin and C1-Inhibitor to enhance therapeutic outcomes.
Latest Patents
Milan Basta holds a patent for a method titled "Combination therapy using immunoglobulin and C1-Inhibitor." This patent discloses methods for treating cerebral ischemia by utilizing a combination of C1-INH and immunoglobulin, such as human plasma-derived immunoglobulin (IVIG). This innovative therapy has the potential to improve patient outcomes in critical medical situations.
Career Highlights
Throughout his career, Milan has worked with notable organizations, including CSL Behring GmbH and the Government of the United States of America. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Milan has collaborated with esteemed colleagues, including Xinzhi Chen and Mark Mattson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking therapies.
Conclusion
Milan Basta's contributions to the field of medicine through his innovative patent and collaborations highlight his dedication to improving healthcare. His work exemplifies the impact that inventors can have on medical science and patient care.